On Friday, the U.S. Food and Drug Administration (FDA) approved Cytokinetics Incorporated’s (NASDAQ: CYTK) Myqorzo (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve ...

The US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve ...

Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos. Cytokinetics has won FDA approval of its ...

A defining metropolis with an ever-growing population of over 12 million people, São Paulo is Brazil’s largest city and capital of the wealthiest state in the country. A mosaic of influences from ...

"This is a historic moment for our company and for the patients we serve, as we fulfill our promise to translate our science into medicines that may make a meaningful difference in patients’ lives,” ...

The match will be played at the Neo Química Arena, São Paulo, Brazil Cornithians will lock horns with Vasco da Gama in the first leg of the finals of Copa do Brasil at Neo Química Arena stadium, São ...